SCLX Scilex Holding Company - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q May 20, 2026SCLX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
SCLX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| June 16, 2026 | 803-for-500 | Forward |
| April 15, 2025 | 1-for-35 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SCLX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | -0.1 | · | · | · | |
| Price / Tangible Book (MRQ) | -0.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SCLX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.1 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2026 | May 20, 2026 | $-4.76 | — | — |
| Dec. 31, 2025 | $-2.21 | $-0.48 | -361.0% | |
| Sept. 30, 2025 | $-21.05 | $-0.84 | -2416.7% | |
| June 30, 2025 | $-3.79 | $-0.93 | -308.3% | |
| March 31, 2025 | $-2.26 | $-1.25 | -80.9% | |
| Dec. 31, 2024 | $0.00 | $-6.96 | 100.0% | |
| Sept. 30, 2024 | $-1.05 | $-5.95 | 82.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $9M | $5M | $16M | |
| Cost of Revenue | $17M | $13M | $4M | |
| Gross Profit | $26M | $18M | · | |
| R&D Expense | $3M | $2M | $2M | |
| SG&A Expense | $31M | $28M | $25M | |
| Operating Income | $-32M | $-28M | $-16M | |
| Interest Expense | · | · | $571.0K | |
| Other Non-op | $-13M | $2M | · | |
| Pretax Income | $-46M | $-26M | $-38M | |
| Income Tax | · | · | $0 | |
| Net Income | $-46M | $-26M | $-38M | |
| EPS (Basic) | $-6.28 | $-2.26 | $-0.31 | |
| EPS (Diluted) | $-6.28 | $-2.26 | $-0.31 | |
| Shares (Basic) | 6,891,000 | 11,565,000 | 120,188 | |
| Shares (Diluted) | 6,891,000 | 11,565,000 | 120,188 | |
| EBITDA | $-29M | · | $-16M |
Balance Sheet
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Cash & Equivalents | $3M | · | $7M | |
| Receivables | $11M | · | $38M | |
| Inventory | $5M | · | $3M | |
| Current Assets | $42M | · | $50M | |
| PP&E (Net) | $13M | · | $714.0K | |
| PP&E (Gross) | $14M | · | $753.0K | |
| Accum. Depreciation | $1M | · | $39.0K | |
| Goodwill | $13M | · | $13M | |
| Intangibles | $60M | · | $34M | |
| Total Assets | $294M | · | $105M | |
| Accounts Payable | $102M | · | $42M | |
| Current Liabilities | $502M | · | $255M | |
| Capital Leases | $13M | · | $2M | |
| Other Non-current Liabilities | $177.0K | · | $187.0K | |
| Total Liabilities | $548M | · | $319M | |
| Common Stock | $1.0K | · | $18.0K | |
| Paid-in Capital | $799M | · | $426M | |
| Retained Earnings | $-965M | · | $-552M | |
| Treasury Stock | $77M | · | $91M | |
| AOCI | $-7M | · | $2M | |
| Stockholders' Equity | $-249M | · | $-215M | |
| Liabilities + Equity | $294M | · | $105M | |
| Shares Outstanding | 8,491,267 | · | 121,405,037 |
Cash Flow
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| D&A | $3M | $1M | · | |
| Stock-based Comp | $4M | $3M | · | |
| Amort. of Intangibles | $2M | $1M | $1M | |
| Other Non-cash | $38M | · | · | |
| Operating Cash Flow | $-1M | $6M | · | |
| Investing Cash Flow | $-9M | $-395.0K | · | |
| Stock Issued | · | · | $15M | |
| Financing Cash Flow | $9M | $-3M | · | |
| Net Change in Cash | $-2M | $3M | · |
Profitability
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Gross Margin | 298.4% | · | · | |
| Operating Margin | -373.5% | · | -95.4% | |
| Net Margin | -530.0% | · | -229.6% | |
| Pretax Margin | -530.0% | · | -229.6% | |
| EBITDA Margin | -340.2% | · | -95.4% | |
| ROA | -24.5% | · | -32.5% | |
| ROE | 19.8% | · | 36.8% | |
| ROIC | · | · | 7.3% |
Liquidity & Solvency
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Current Ratio | 0.1 | · | 0.2 | |
| Quick Ratio | 0.0 | · | 0.2 | |
| Interest Coverage | · | · | -27.4 |
Efficiency
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.1 | |
| Inventory Turnover | 4.5 | · | 1.4 | |
| Receivables Turnover | 0.8 | · | 0.5 |
Per Share
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Book Value / Share | $-29.35 | · | $-1.77 | |
| Revenue / Share | $1.25 | · | $136.20 | |
| Cash Flow / Share | $-0.16 | · | · | |
| Cash / Share | $0.39 | · | $0.06 |
Valuation (TTM)
| Metric | Trend | Q1 2026 | Q1 2025 | Q2 2024 |
|---|---|---|---|---|
| Market Cap | $57M | · | $8.20B | |
| P/B | -0.2 | · | -38.2 | |
| P / Cash Flow | -51.1 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 77 filers · $9.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 9 (+1 vs prior Q) | 10 (0 vs prior Q) | 13 (+5 vs prior Q) | 7 (-8 vs prior Q) | -169K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3,599,293 | 295,024 | 39.36% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,350,078 | 301,292 | 25.70% | Shares |
| BlackRock, Inc. | $853,453 | 109,417 | 9.33% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $357,412 | 45,822 | 3.91% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $321,071 | 41,163 | 3.51% | Shares |
| STATE STREET CORP | $275,933 | 35,376 | 3.02% | Shares |
| UBS Group AG | $260,333 | 33,376 | 2.85% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $257,899 | 33,064 | 2.82% | Shares |
| Donald L. Hagan, LLC | $233,661 | 11,873 | 2.56% | Shares |
| CITADEL ADVISORS LLC | $214,477 | 27,497 | 2.35% | Shares |
| Ashton Thomas Private Wealth, LLC | $144,160 | 18,482 | 1.58% | Shares |
| NORTHERN TRUST CORP | $117,367 | 15,047 | 1.28% | Shares |
| MORGAN STANLEY | $31,454 | 4,032 | 0.34% | Shares |
| Vanguard Global Advisers, LLC | $22,909 | 2,937 | 0.25% | Shares |
| OSAIC HOLDINGS, INC. | $18,236 | 2,339 | 0.20% | Shares |
| CREATIVE FINANCIAL DESIGNS INC /ADV | $14,453 | 1,853 | 0.16% | Shares |
| ROYAL BANK OF CANADA | $14,000 | 1,745 | 0.15% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $12,478 | 1,755 | 0.14% | Shares |
| Larson Financial Group LLC | $11,068 | 1,419 | 0.12% | Shares |
| MetLife Investment Management, LLC | $8,502 | 1,090 | 0.09% | Shares |
| DEUTSCHE BANK AG\ | $6,240 | 800 | 0.07% | Shares |
| IFP Advisors, Inc | $4,493 | 576 | 0.05% | Shares |
| MCF Advisors LLC | $3,698 | 474 | 0.04% | Shares |
| Activest Wealth Management | $2,356 | 302 | 0.03% | Shares |
| KLP KAPITALFORVALTNING AS | $2,262 | 290 | 0.02% | Shares |
| GAMMA Investing LLC | $905 | 116 | 0.01% | Shares |
| IFG Advisory, LLC | $624 | 80 | 0.01% | Shares |
| S&T Bank/PA | $608 | 78 | 0.01% | Shares |
| WELLS FARGO & COMPANY/MN | $499 | 64 | 0.01% | Shares |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $343 | 44 | 0.00% | Shares |
| RHUMBLINE ADVISERS | $273 | 35 | 0.00% | Shares |
| Spectrum Wealth Advisory Group, LLC | $231 | 29 | 0.00% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $226 | 29 | 0.00% | Shares |
| TD Waterhouse Canada Inc. | $212 | 27 | 0.00% | Shares |
| New England Capital Financial Advisors LLC | $180 | 23 | 0.00% | Shares |
| NFSG Corp | $172 | 22 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $164 | 20,920 | 0.00% | Shares |
| Operose Advisors LLC | $156 | 20 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $140 | 18 | 0.00% | Shares |
| Global Retirement Partners, LLC | $125 | 16 | 0.00% | Shares |
| NewEdge Advisors, LLC | $109 | 14 | 0.00% | Shares |
| Pacifica Partners Inc. | $108 | 14 | 0.00% | Shares |
| HARBOUR INVESTMENTS, INC. | $101 | 13 | 0.00% | Shares |
| SOA Wealth Advisors, LLC. | $101 | 13 | 0.00% | Shares |
| Sachetta, LLC | $94 | 12 | 0.00% | Shares |
| VALLEY NATIONAL ADVISERS INC | $94 | 12 | 0.00% | Shares |
| CoreCap Advisors, LLC | $94 | 12 | 0.00% | Shares |
| US BANCORP \DE\ | $86 | 11 | 0.00% | Shares |
| CIBC Private Wealth Group LLC | $79 | 4 | 0.00% | Shares |
| State of Wyoming | $74 | 9 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Scilex Holding Company, Scilex, Inc. ×2 filings | Sept. 26, 2025 | 79.89% | Initial filing | · | SEC |
| SCLX Stock Acquisition JV LLC ×4 filings | April 25, 2024 | · | Initial filing | · | SEC |
| Sorrento Therapeutics, Inc. ×4 filings | Sept. 26, 2023 | · | Initial filing | · | SEC |
| Sorrento Therapeutics, Inc . | Jan. 23, 2023 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 15 insiders · 4 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Henry Ji | Exec Chair, CEO and President | April 17, 2026 S | 320,161 | 1 | 1 | $390,000 |
| Jaisim Shah | Chief Executive Officer and President | Dec. 18, 2024 P | 139,333 | 0 | 0 | $0 |
| Stephen Hoi Ma | CFO, COO and Secretary | April 17, 2026 P | 22,840 | 1 | 0 | $97,500 |
| Elizabeth Czerepak | Executive Vice President, Chief Business Officer and Chief Financial Officer | Jan. 17, 2023 A | · | 0 | 0 | $0 |
| Jay Chun | Director | Oct. 8, 2025 A | 112,500 | 0 | 0 | $0 |
| Dorman Followwill | Director | Oct. 8, 2025 A | 2,300 | 0 | 0 | $0 |
| Yue Alexander Wu | Director | Oct. 8, 2025 A | 25,000 | 0 | 0 | $0 |
| David Lemus | Director | Oct. 17, 2024 P | 2,000 | 0 | 0 | $0 |
| Annu Navani | Director | Aug. 16, 2024 A | · | 0 | 0 | $0 |
| Tien-Li Lee | Director | Jan. 17, 2023 A | · | 0 | 0 | $0 |
| Laura Hamill | Director | Jan. 17, 2023 A | · | 0 | 0 | $0 |
| Tommy G Thompson | Director | Jan. 17, 2023 A | · | 0 | 0 | $0 |
| Scilex Holding Co | 10% owner | Dec. 30, 2025 S | 244,445,260 | 0 | 3 | $-12,806,953 |
| SCLX Stock Acquisition JV LLC | 10% owner | Jan. 21, 2025 J | 51,039,214 | 0 | 0 | $0 |
| Sorrento Therapeutics, Inc. | 10% owner | Sept. 21, 2023 S | 1,917,210 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
SCLX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.